Literature DB >> 18998571

[Screening on alkaloid of Sophora alopecuraides against adenocarcinoma of colon cell line SW620 in vitro].

Lei Liang1, Xiao-Yan Wang, Xu-Hui Zhang, Wen-Chang Zhao, Hong-Zhu Deng.   

Abstract

OBJECTIVE: To test 5 kinds of alkaloid of Sophora alopecuraides L., the effects of TBSA, MT, OMT, SC, SRI against adenocarcinoma of colon cell line SW620.
METHODS: SW620 cell line was treated with alkaloid at various concentrations. The effect on cell proliferative activity was measured by MTT assay and the effects of alkaloids against cell growth were compared. The changes of cell morphology were observed through optical microscope and fluorescence microscope and the cell apoptosis was detected by flow cytometry and Annexin V-FITC apoptosis assay after the treatments.
RESULTS: According to the results of MTT assay, all of the 5 kinds of alkaloid especially SRI and MT were identified to produce growth inhibition against SW620 cells. The sequence of the intensity of effect was TBSA < OMT < SC < MT < SRI. Further study of SRI and MT demonstrated their effects on inducing SW620 cell apoptosis, and SRI showed the strongest effect. Both SRI and MT induced SW620 cells to apoptosis in a dose-and-time-dependent manner.
CONCLUSION: The 5 kinds of alkaloid especially SRI and MT may inhibit the growth of SW620 cells,and induce SW620 cell apoptosis. The results of this study pave the way for further identification of the effective components in Sophora alopecuraides L. that inhibit colorectal carcinoma both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998571

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  2 in total

1.  Effects of ethanol extract of Radix Sophorae Flavescentis on activity of colon cancer HT29 cells.

Authors:  Zhi-Ming Xiao; Ai-Min Wang; Xiao-Yan Wang; Shou-Rong Shen
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

Review 2.  Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review.

Authors:  Maciej Sałaga; Hubert Zatorski; Marta Sobczak; Chunqiu Chen; Jakub Fichna
Journal:  Curr Treat Options Oncol       Date:  2014-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.